Impact of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers on clinical outcomes in hypertensive patients with acute myocardial infarction.

Impact of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers on clinical outcomes in hypertensive patients with acute myocardial infarction.

Show other versions (1)

There has been a concern that angiotensin receptor blockers (ARB) may increase myocardial infarction (MI) in hypertensive patients compared with other classes of anti-hypertensive drugs. Angiotensin-converting enzyme inhibitor (ACEI) is recommended as a first-line inhibitor of renin-angiotensin syst...

Full description

Bibliographic Details
Main Authors: Jae-Geun Lee, Seung-Jae Joo, Song-Yi Kim, Joon-Hyouk Choi, Ki Yung Boo, Jin-Yong Hwang, Seung-Ho Hur, Myung Ho Jeong, KAMIR-NIH investigators
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0281460

Similar Items

Similar Items